Amylyx Pharmaceuticals Inc
AMLX12.330USD
-0.160-1.28%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.35BMarket Cap
LossP/E TTM
Amylyx Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
87.37M
-77.06%
EPS(YoY)
-4.43
-704.26%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 87.37M, with a year-on-year change of -77.06%.
What is the Earnings Per Share (EPS) of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -4.428, with a year-on-year change of -704.26%.
What is the net income of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its net income was -301.74M, with a year-on-year change of -712.42%.
What is the net margin of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -345.36%, with a year-on-year change of -2769.07%.
What is the gross margin of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 63.22%, with a year-on-year change of -32.25%.
What is the debt-to-asset ratio of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -100.88%, with a year-on-year change of -892.44%.
What is the Return on Assets (ROA) of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -84.87%, with a year-on-year change of -882.78%.
What is the operating profit of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -163.18M, with a year-on-year change of -520.54%.
What are the current assets of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its current assets were 189.43M, with a year-on-year change of -59.23%.
What are the total assets of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its total assets of Amylyx Pharmaceuticals Inc were 193.63M, with a year-on-year change of -62.58%.
What are the total liabilities of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Amylyx Pharmaceuticals Inc were 28.87M, with a year-on-year change of -65.64%.
What is the total equity of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its total equity of Amylyx Pharmaceuticals Inc was 164.76M, with a year-on-year change of -61.99%.
What is the net operating income of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Amylyx Pharmaceuticals Inc was -301.74M, with a year-on-year change of -712.42%.
What is the net investment of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its net investment of Amylyx Pharmaceuticals Inc was 75.65M, with a year-on-year change of -17.81%.
What is the net financing of Amylyx Pharmaceuticals Inc?
According to Amylyx Pharmaceuticals Inc's FY2024 earnings report, its net financing of Amylyx Pharmaceuticals Inc was 348.00K, with a year-on-year change of -90.18%.
